Related Experiment Video
Updated: Mar 17, 2026

RhoC GTPase Activation Assay
Published on: August 22, 2010
Rho GTPase RhoJ is Associated with Gastric Cancer Progression and Metastasis
Chan Kim1, Hannah Yang2, Intae Park2
11. Medical Oncology, CHA Bundang Medical Center, CHA University, Seongnam, Korea;; 2. Laboratory of Tumor Vasculature and Microenvironment, CHA University, Seongnam, Korea;
Abstract:
Rho GTPases play a pivotal role in tumor progression by regulating tumor cell migration and invasion. However, the role of Rho GTPases in gastric cancer (GC) remains unexplored. This study aimed to investigate the clinical implications of RhoJ, which is an uncharted member of Rho family. RhoJ expression in human GC cell lines and surgical specimens from GC patients were analyzed. Moreover, in vitro gain-of-function analysis was performed to evaluate the malignant phenotypes of RhoJ-overexpressing GC cells. The extent of RhoJ expression varied among GC cell lines and GC patients. YCC-9 cell line displayed the strongest expression, while YCC-10, -11, and -16 showed scant expressions. Of the 70 GC patients, 34 (48.6%) had RhoJ expression in their GC tissue, and patients with high RhoJ expression had more diffuse type GC (73.5% vs. 41.7%), were at more advanced stages (stage III, IV: 85.3% vs. 58.4%), and had more frequent metastasis (47.1% vs. 11.1%), denoting that RhoJ has a potential role in GC progression and metastasis. High RhoJ expression significantly correlated with poor overall survival and recurrence-free survival after surgical resection of gastric cancer. Finally, In vitro gain-of-function experiments showed 41.3% enhanced motility and 60.4% enhanced invasiveness in RhoJ-overexpressing GC cells compared to control, with negligible difference in cell proliferation. Collectively, high RhoJ expression is an independent negative prognostic factor for the survival outcome of GC and correlated with the increased cell motility and invasiveness.
Insights
RhoJ, a Rho GTPase, promotes gastric cancer (GC) progression and metastasis. High RhoJ expression indicates poor survival and increased cell motility, suggesting it as a negative prognostic factor for GC patients.
Area of Science:
- Molecular Biology
- Oncology
- Cell Biology
Background:
- Rho GTPases are crucial for tumor cell migration and invasion.
- The role of Rho GTPases in gastric cancer (GC) pathogenesis is largely unknown.
- RhoJ is an understudied member of the Rho GTPase family.
Purpose of the Study:
- To investigate the clinical significance and functional role of RhoJ in gastric cancer.
- To determine if RhoJ expression correlates with GC progression, metastasis, and patient survival.
Main Methods:
- Analysis of RhoJ expression in GC cell lines and patient tumor samples.
- In vitro gain-of-function studies to assess RhoJ's impact on GC cell phenotypes.
- Correlation analysis between RhoJ expression and clinical parameters, including survival and recurrence.
Main Results:
- RhoJ expression varied across GC cell lines and patient tissues.
- High RhoJ expression was associated with diffuse type GC, advanced stages, and increased metastasis.
- Elevated RhoJ levels significantly correlated with poorer overall and recurrence-free survival.
- RhoJ overexpression enhanced GC cell motility (41.3%) and invasiveness (60.4%) without affecting proliferation.
Conclusions:
- High RhoJ expression is an independent negative prognostic factor for gastric cancer survival.
- RhoJ promotes GC progression and metastasis by increasing cell motility and invasiveness.
More Related Videos
13:51Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay
Published on: November 11, 2018
10:28Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
Related Concept Videos
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
The Ras Gene
Ras is a...
Cell Polarization by Rho Proteins
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...